-
Global Markets for Treatments for Syndromes of Progressive Ataxia and Weakness Disorders Published: September, 2023 - Pages: 180
-
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 Published: September, 2021 - Pages: 113
-
Friedreich Ataxia (Central Nervous System) - Drugs In Development, 2021 Published: July, 2021 - Pages: 172
-
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Drugs In Development, 2021 Published: June, 2021 - Pages: 77
-
Ataxin 3 (Machado Joseph Disease Protein 1 or Spinocerebellar Ataxia Type 3 Protein or SCA3 or ATXN3 or EC 3.4.19.12) - ... Published: April, 2021 - Pages: 35
-
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) - Drugs in Development, 2021 Published: March, 2021 - Pages: 35
-
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020 Published: November, 2020 - Pages: 114
-
Serine Protein Kinase ATM (Ataxia Telangiectasia Mutated or ATM or EC 2.7.11.1) Development by Therapy Areas and Indicat... Published: March, 2022 - Pages: 36
-
Spinocerebellar Ataxia (SCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Updat... Published: September, 2022 - Pages: 91
-
Global Friedreich's Ataxia Treatment Market -2023-2030 Published: November, 2023 - Pages: 186